Papers

2

Total Citations

33

H-Index

2

About

Dr. Xu Che is a leading surgical oncologist whose research focuses on advancing the safety and efficacy of complex hepatopancreaticobiliary surgeries, particularly through the integration of robotic technology. His most impactful contribution is a landmark meta-analysis examining the safety and efficacy of robot-assisted versus open pancreaticoduodenectomy across multiple worldwide centers, which has garnered 27 citations and provides crucial evidence for minimally invasive approaches in this challenging procedure. Dr. Che has also made significant contributions to improving surgical outcomes for ampullary carcinoma patients, analyzing textbook outcomes following pancreaticoduodenectomy to establish quality benchmarks for care. Additionally, his work addresses the persistent challenge of postcholecystectomy bile duct injury, a devastating iatrogenic complication that continues to impact patient quality of life despite declining incidence. Through his systematic analyses of surgical techniques and outcomes, Dr. Che is helping to define best practices in pancreatic surgery while advancing the evidence base for robotic-assisted approaches that may reduce complications and improve recovery for patients undergoing these complex procedures.

Research Focus

Key Achievements

2
H-Index
2
Papers
33
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Safety and efficacy of robot-assisted versus open pancreaticoduodenectomy: a meta-analysis of multiple worldwide centers
27 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago